Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of PF-06480605 in adults with moderate to severe ulcerative colitis has completed. Results were posted on 2025-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PF-06480605

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Moderate to Severe Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2025-12-16